Breakthrough Exophiala dermatitidis infection during prophylactic administration of micafungin during second umbilical cord blood transplantation after graft failure

Transpl Infect Dis. 2018 Apr;20(2):e12833. doi: 10.1111/tid.12833. Epub 2018 Feb 12.

Abstract

Exophiala dermatitidis infections in patients with hematological malignancies are very rare. Our patient had a blood stream infection caused by E. dermatitidis following the second umbilical cord blood transplantation (UCBT) after graft failure during the first UCBT. To our knowledge, this is the first report describing a breakthrough fungal infection caused by E. dermatitidis during the prophylactic administration of micafungin (MCFG). Therefore, MCFG-treated patients should be monitored for breakthrough E. dermatitidis infection during hematopoietic stem cell transplantation.

Keywords: Exophiala dermatitidis; breakthrough fungal infection; liposomal amphotericin B; umbilical cord blood transplantation.

Publication types

  • Case Reports

MeSH terms

  • Antifungal Agents / therapeutic use
  • Cord Blood Stem Cell Transplantation
  • Echinocandins / therapeutic use*
  • Exophiala*
  • Fatal Outcome
  • Graft vs Host Disease
  • Humans
  • Immunocompromised Host
  • Lipopeptides / therapeutic use*
  • Male
  • Micafungin
  • Middle Aged
  • Phaeohyphomycosis / drug therapy*
  • Phaeohyphomycosis / etiology*
  • Primary Myelofibrosis / therapy*

Substances

  • Antifungal Agents
  • Echinocandins
  • Lipopeptides
  • Micafungin